Stockreport

AVEO Oncology, an LG Chem company, Presents Two Posters for Tivozanib at the 2025 ASCO GU Meeting [Yahoo! Finance]

KIRIN HLDGS CO LTD S/ADR  (KNBWY) 
US:NASDAQ Investor Relations: kirinholdings.co.jp/english/ir
PDF 8 min read – Cumulative data of three Phase 3 studies demonstrate greater exposure of tivozanib is associated with increased clinical benefit – – Patient Reported Out [Read more]